{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:12:03Z","timestamp":1781781123798,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      VCP disease, also known as multisystem proteinopathy, is a rare, autosomal dominant, adult-onset, neuromuscular disease that is caused by variants in the valosin-containing protein (\n                      <jats:italic>VCP<\/jats:italic>\n                      ) gene. VCP disease may exhibit one or more of the following primary features: inclusion body myopathy, Paget\u2019s disease of bone (PDB), Frontotemporal dementia, and amyotrophic lateral sclerosis. Due to its\u00a0progressive nature, death normally occurs in their sixties due to respiratory and cardiac failure. The purpose of this study is to utilize the Cure VCP Disease patient registry hosted by the Coordination of Rare Diseases at Sanford (CoRDS) to conduct a prospective natural history study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Seventy-nine participants enrolled in the patient registry and answered demographic,\n                      <jats:italic>VCP<\/jats:italic>\n                      variant type, Patient-reported outcome measures (PROMs), and quality of life (QOL) questionnaires over the course of 3\u00a0years. We additionally investigated if any sex differences existed and if genotype\u2013phenotype correlations affected the rate of progression of the varying clinical manifestations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, participants\u2019 mobility declined significantly as the disease progressed. Participants reported a 0.6% decline in upper extremity function, 1.2% decline in lower extremity function, and 0.3% decline in cognitive function per year of age. Furthermore, participants reported a 1.6% decline in upper and lower extremity function and a 0.1% decline in cognitive function per year of disease duration. The highest PROMs correlations were noted between overall health and lower extremity function, upper extremity function, fatigue, and the ability to perform vigorous activities. Genotype\u2013phenotype correlations revealed no significant differences except for the absence of PDB in the\n                      <jats:italic>p<\/jats:italic>\n                      .\n                      <jats:italic>Arg159Cys<\/jats:italic>\n                      group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The VCP CoRDS Registry was found to be a valuable tool for monitoring the QOL in patients with VCP disease and capturing patient perspectives for future clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03567-w","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:16:56Z","timestamp":1744658216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of CoRDS registry to monitor quality of life in patients with VCP multisystem proteinopathy"],"prefix":"10.1186","volume":"20","author":[{"given":"Eiman","family":"Abdoalsadig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merwa","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leepakshi","family":"Johar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-4449","authenticated-orcid":false,"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"4","key":"3567_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00125817-200007000-00006","volume":"2","author":"VE Kimonis","year":"2000","unstructured":"Kimonis VE, Kovach MJ, Waggoner B, Leal S, Salam A, Rimer L, et al. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med. 2000;2(4):232\u201341. https:\/\/doi.org\/10.1097\/00125817-200007000-00006.","journal-title":"Genet Med"},{"issue":"4","key":"3567_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1006\/mgme.2001.3256","volume":"74","author":"MJ Kovach","year":"2001","unstructured":"Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74(4):458\u201375. https:\/\/doi.org\/10.1006\/mgme.2001.3256.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3567_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GD Watts","year":"2004","unstructured":"Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377\u201381. https:\/\/doi.org\/10.1038\/ng1332.","journal-title":"Nat Genet"},{"key":"3567_CR4","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1242\/jcs.093831","volume":"127","author":"H Meyer","year":"2014","unstructured":"Meyer H, Weihl CC. The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877\u201383. https:\/\/doi.org\/10.1242\/jcs.093831.","journal-title":"J Cell Sci"},{"issue":"2","key":"3567_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1128\/MCB.22.2.626-634.2002","volume":"22","author":"E Rabinovich","year":"2002","unstructured":"Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S. AAA-ATPase p97\/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol. 2002;22(2):626\u201334. https:\/\/doi.org\/10.1128\/MCB.22.2.626-634.2002.","journal-title":"Mol Cell Biol"},{"key":"3567_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/genes13060963","author":"G Pfeffer","year":"2022","unstructured":"Pfeffer G, Lee G, Pontifex CS, Fanganiello RD, Peck A, Weihl CC, et al. Multisystem proteinopathy due to VCP mutations: a review of clinical heterogeneity and genetic diagnosis. Genes (Basel). 2022. https:\/\/doi.org\/10.3390\/genes13060963.","journal-title":"Genes (Basel)"},{"issue":"11","key":"3567_CR7","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1074\/jbc.M111.302778","volume":"287","author":"H Niwa","year":"2012","unstructured":"Niwa H, Ewens CA, Tsang C, Yeung HO, Zhang X, Freemont PS. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97\/VCP. J Biol Chem. 2012;287(11):8561\u201370. https:\/\/doi.org\/10.1074\/jbc.M111.302778.","journal-title":"J Biol Chem"},{"key":"3567_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-328921","author":"M Schiava","year":"2022","unstructured":"Schiava M, Ikenaga C, Villar-Quiles RN, Caballero-Avila M, Topf A, Nishino I, et al. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study. J Neurol Neurosurg Psychiatry. 2022. https:\/\/doi.org\/10.1136\/jnnp-2022-328921.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"3567_CR9","doi-asserted-by":"publisher","first-page":"e200191","DOI":"10.1212\/NXG.0000000000200191","volume":"10","author":"SE Robinson","year":"2024","unstructured":"Robinson SE, Findlay AR, Li S, Wang F, Schiava M, Daw J, et al. Elevated VCP ATPase activity correlates with disease onset in multisystem proteinopathy-1. Neurol Genet. 2024;10(5):e200191. https:\/\/doi.org\/10.1212\/NXG.0000000000200191.","journal-title":"Neurol Genet"},{"issue":"5","key":"3567_CR10","doi-asserted-by":"publisher","first-page":"e200093","DOI":"10.1212\/NXG.0000000000200093","volume":"9","author":"M Schiava","year":"2023","unstructured":"Schiava M, Ikenaga C, Topf A, Caballero-Avila M, Chou TF, Li S, et al. Clinical classification of variants in the valosin-containing protein gene associated with multisystem proteinopathy. Neurol Genet. 2023;9(5):e200093. https:\/\/doi.org\/10.1212\/NXG.0000000000200093.","journal-title":"Neurol Genet"},{"issue":"1","key":"3567_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.13095","volume":"93","author":"E Al-Obeidi","year":"2018","unstructured":"Al-Obeidi E, Al-Tahan S, Surampalli A, Goyal N, Wang AK, Hermann A, et al. Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin Genet. 2018;93(1):119\u201325. https:\/\/doi.org\/10.1111\/cge.13095.","journal-title":"Clin Genet"},{"issue":"10","key":"3567_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79(10):1186\u20139. https:\/\/doi.org\/10.1136\/jnnp.2007.131334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3567_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1359\/jbmr.090709","volume":"25","author":"AL Langston","year":"2010","unstructured":"Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH, et al. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget\u2019s disease of bone. J Bone Miner Res. 2010;25(1):20\u201331. https:\/\/doi.org\/10.1359\/jbmr.090709.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"3567_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/rheumatology\/keh243","volume":"43","author":"AL Langston","year":"2004","unstructured":"Langston AL, Ralston SH. Management of Paget\u2019s disease of bone. Rheumatology. 2004;43(8):955\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keh243.","journal-title":"Rheumatology"},{"issue":"4","key":"3567_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jbmr.3657","volume":"34","author":"SH Ralston","year":"2019","unstructured":"Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, et al. Diagnosis and management of Paget\u2019s disease of bone in adults: a clinical guideline. J Bone Miner Res. 2019;34(4):579\u2013604. https:\/\/doi.org\/10.1002\/jbmr.3657.","journal-title":"J Bone Miner Res"},{"key":"3567_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/brain\/awl238","volume":"130","author":"CU Hubbers","year":"2007","unstructured":"Hubbers CU, Clemen CS, Kesper K, Boddrich A, Hofmann A, Kamarainen O, et al. Pathological consequences of VCP mutations on human striated muscle. Brain. 2007;130:381\u201393. https:\/\/doi.org\/10.1093\/brain\/awl238.","journal-title":"Brain"},{"issue":"1","key":"3567_CR17","doi-asserted-by":"publisher","first-page":"209.e1","DOI":"10.1016\/j.neurobiolaging.2011.07.011","volume":"33","author":"E Majounie","year":"2012","unstructured":"Majounie E, Traynor BJ, Chio A, Restagno G, Mandrioli J, Benatar M, et al. Mutational analysis of the VCP gene in Parkinson\u2019s disease. Neurobiol Aging. 2012;33(1):209.e1-2. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.07.011.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3567_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cge.12000","volume":"83","author":"SG Mehta","year":"2013","unstructured":"Mehta SG, Khare M, Ramani R, Watts GD, Simon M, Osann KE, et al. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and\/or frontotemporal dementia. Clin Genet. 2013;83(5):422\u201331. https:\/\/doi.org\/10.1111\/cge.12000.","journal-title":"Clin Genet"},{"issue":"1","key":"3567_CR19","doi-asserted-by":"publisher","first-page":"e200037","DOI":"10.1212\/NXG.0000000000200037","volume":"9","author":"A Shmara","year":"2023","unstructured":"Shmara A, Gibbs L, Mahoney RP, Hurth K, Goodwill VS, Cuber A, et al. Prevalence of frontotemporal dementia in females of 5 Hispanic families with R159H VCP multisystem proteinopathy. Neurol Genet. 2023;9(1):e200037. https:\/\/doi.org\/10.1212\/NXG.0000000000200037.","journal-title":"Neurol Genet"},{"issue":"1","key":"3567_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13023-022-02172-5","volume":"17","author":"M Korb","year":"2022","unstructured":"Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, et al. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet J Rare Dis. 2022;17(1):23. https:\/\/doi.org\/10.1186\/s13023-022-02172-5.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3567_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbadis.2008.09.003","volume":"1782","author":"VE Kimonis","year":"2008","unstructured":"Kimonis VE, Fulchiero E, Vesa J, Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta. 2008;1782(12):744\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2008.09.003.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"3567_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/acn3.51760","volume":"10","author":"B Roy","year":"2023","unstructured":"Roy B, Peck A, Evangelista T, Pfeffer G, Wang L, Diaz-Manera J, et al. Provisional practice recommendation for the management of myopathy in VCP-associated multisystem proteinopathy. Ann Clin Transl Neurol. 2023;10(5):686\u201395. https:\/\/doi.org\/10.1002\/acn3.51760.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"3567_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13023-020-01551-0","volume":"15","author":"C Ikenaga","year":"2020","unstructured":"Ikenaga C, Findlay AR, Seiffert M, Peck A, Peck N, Johnson NE, et al. Phenotypic diversity in an international cure VCP disease registry. Orphanet J Rare Dis. 2020;15(1):267. https:\/\/doi.org\/10.1186\/s13023-020-01551-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"23","key":"3567_CR24","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","volume":"78","author":"D Cella","year":"2012","unstructured":"Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012;78(23):1860\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318258f744.","journal-title":"Neurology"},{"issue":"1","key":"3567_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJMp1702978","volume":"377","author":"JF Baumhauer","year":"2017","unstructured":"Baumhauer JF. Patient-reported outcomes - are they living up to their potential? N Engl J Med. 2017;377(1):6\u20139. https:\/\/doi.org\/10.1056\/NEJMp1702978.","journal-title":"N Engl J Med"},{"issue":"6","key":"3567_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s43441-020-00184-6","volume":"54","author":"L Lasiter","year":"2020","unstructured":"Lasiter L, Campbell A, Basch E, Hudgens S, Stewart M, Wu JJ, et al. Use of patient-reported outcomes to understand & measure the patient experience of novel cell and gene therapies. Ther Innov Regul Sci. 2020;54(6):1566\u201375. https:\/\/doi.org\/10.1007\/s43441-020-00184-6.","journal-title":"Ther Innov Regul Sci"},{"issue":"6","key":"3567_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.nmd.2021.02.018","volume":"31","author":"A LoMauro","year":"2021","unstructured":"LoMauro A, Gandossini S, Russo A, Diella E, Pistininzi C, Marchi E, et al. Over three decades of natural history of limb girdle muscular dystrophy type R1\/2A and R2\/2B: mathematical modelling of a multifactorial study. Neuromuscul Disord. 2021;31(6):489\u201397. https:\/\/doi.org\/10.1016\/j.nmd.2021.02.018.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"3567_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/acn3.774","volume":"6","author":"AP Murphy","year":"2019","unstructured":"Murphy AP, Morrow J, Dahlqvist JR, Stojkovic T, Willis TA, Sinclair CDJ, et al. Natural history of limb girdle muscular dystrophy R9 over 6\u00a0years: searching for trial endpoints. Ann Clin Transl Neurol. 2019;6(6):1033\u201345. https:\/\/doi.org\/10.1002\/acn3.774.","journal-title":"Ann Clin Transl Neurol"},{"key":"3567_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0142-8","volume":"8","author":"L Tang","year":"2019","unstructured":"Tang L, Ma Y, Liu XL, Chen L, Fan DS. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener. 2019;8:2. https:\/\/doi.org\/10.1186\/s40035-018-0142-8.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"3567_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1037\/a0023262","volume":"137","author":"TA Salthouse","year":"2011","unstructured":"Salthouse TA. Neuroanatomical substrates of age-related cognitive decline. Psychol Bull. 2011;137(5):753\u201384. https:\/\/doi.org\/10.1037\/a0023262.","journal-title":"Psychol Bull"},{"issue":"11","key":"3567_CR31","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cercor\/bhi044","volume":"15","author":"N Raz","year":"2005","unstructured":"Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 2005;15(11):1676\u201389. https:\/\/doi.org\/10.1093\/cercor\/bhi044.","journal-title":"Cereb Cortex"},{"key":"3567_CR32","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/j.pain.0000000000000775","volume":"158","author":"RB Fillingim","year":"2017","unstructured":"Fillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain. 2017;158:S11\u20138. https:\/\/doi.org\/10.1097\/j.pain.0000000000000775.","journal-title":"Pain"},{"issue":"1","key":"3567_CR33","doi-asserted-by":"publisher","first-page":"e12569","DOI":"10.1002\/rmb2.12569","volume":"23","author":"T Hosoi","year":"2024","unstructured":"Hosoi T, Yakabe M, Hashimoto S, Akishita M, Ogawa S. The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reprod Med Biol. 2024;23(1):e12569. https:\/\/doi.org\/10.1002\/rmb2.12569.","journal-title":"Reprod Med Biol"},{"issue":"1","key":"3567_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/11319760-000000000-00000","volume":"40","author":"DL Enns","year":"2010","unstructured":"Enns DL, Tiidus PM. The influence of estrogen on skeletal muscle: sex matters. Sports Med. 2010;40(1):41\u201358. https:\/\/doi.org\/10.2165\/11319760-000000000-00000.","journal-title":"Sports Med"},{"key":"3567_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fgene.2015.00179","volume":"6","author":"V Orgogozo","year":"2015","unstructured":"Orgogozo V, Morizot B, Martin A. The differential view of genotype-phenotype relationships. Front Genet. 2015;6:179. https:\/\/doi.org\/10.3389\/fgene.2015.00179.","journal-title":"Front Genet."},{"key":"3567_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/nu10070815","author":"C Agostinis-Sobrinho","year":"2018","unstructured":"Agostinis-Sobrinho C, Santos R, Rosario R, Moreira C, Lopes L, Mota J, et al. Optimal adherence to a mediterranean diet may not overcome the deleterious effects of low physical fitness on cardiovascular disease risk in adolescents: a cross-sectional pooled analysis. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10070815.","journal-title":"Nutrients"},{"issue":"1","key":"3567_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12891-022-05162-7","volume":"23","author":"K Yamada","year":"2022","unstructured":"Yamada K, Adams H, Ellis T, Clark R, Sully C, Lariviere C, et al. The temporal relation between pain and fatigue in individuals receiving treatment for chronic musculoskeletal pain. BMC Musculoskelet Disord. 2022;23(1):219. https:\/\/doi.org\/10.1186\/s12891-022-05162-7.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"3567_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.sjpain.2011.01.005","volume":"2","author":"SJ Linton","year":"2011","unstructured":"Linton SJ, Bergbom S. Understanding the link between depression and pain. Scand J Pain. 2011;2(2):47\u201354. https:\/\/doi.org\/10.1016\/j.sjpain.2011.01.005.","journal-title":"Scand J Pain"},{"issue":"1","key":"3567_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1461145704004729","volume":"8","author":"K Demyttenaere","year":"2005","unstructured":"Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol. 2005;8(1):93\u2013105. https:\/\/doi.org\/10.1017\/S1461145704004729.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"3567_CR40","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029\u201340. https:\/\/doi.org\/10.1017\/S0033291713002535.","journal-title":"Psychol Med"},{"issue":"1","key":"3567_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1980-57642020dn14-010001","volume":"14","author":"NS Dias","year":"2020","unstructured":"Dias NS, Barbosa IG, Kuang W, Teixeira AL. Depressive disorders in the elderly and dementia: an update. Dement Neuropsychol. 2020;14(1):1\u20136. https:\/\/doi.org\/10.1590\/1980-57642020dn14-010001.","journal-title":"Dement Neuropsychol"},{"key":"3567_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1479-5868-7-38","volume":"7","author":"DH Paterson","year":"2010","unstructured":"Paterson DH, Warburton DE. Physical activity and functional limitations in older adults: a systematic review related to Canada\u2019s physical activity guidelines. Int J Behav Nutr Phys Act. 2010;7:38. https:\/\/doi.org\/10.1186\/1479-5868-7-38.","journal-title":"Int J Behav Nutr Phys Act."},{"issue":"10","key":"3567_CR43","doi-asserted-by":"publisher","first-page":"e76187","DOI":"10.1371\/journal.pone.0076187","volume":"8","author":"A Nalbandian","year":"2013","unstructured":"Nalbandian A, Nguyen C, Katheria V, Llewellyn KJ, Badadani M, Caiozzo V, et al. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease. PLoS One. 2013;8(10):e76187. https:\/\/doi.org\/10.1371\/journal.pone.0076187.","journal-title":"PLoS One"},{"key":"3567_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.nmd.2023.12.001","volume":"34","author":"M Halseth","year":"2024","unstructured":"Halseth M, Mahoney R, Hsiou J, Jones HN, Kimonis V. Remote respiratory resistance exercise training improves respiratory function in individuals with VCP multisystem proteinopathy. Neuromuscul Disord. 2024;34:68\u201374. https:\/\/doi.org\/10.1016\/j.nmd.2023.12.001.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"3567_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1369-6513.1998.00004.x","volume":"1","author":"HJ Sixma","year":"1998","unstructured":"Sixma HJ, Kerssens JJ, Campen CV, Peters L. Quality of care from the patients\u2019 perspective: from theoretical concept to a new measuring instrument. Health Expect. 1998;1(2):82\u201395. https:\/\/doi.org\/10.1046\/j.1369-6513.1998.00004.x.","journal-title":"Health Expect"},{"issue":"6","key":"3567_CR46","doi-asserted-by":"publisher","first-page":"e1112","DOI":"10.1097\/PR9.0000000000001112","volume":"8","author":"G Crombez","year":"2023","unstructured":"Crombez G, Veirman E, Van Ryckeghem D, Scott W, De Paepe A. The effect of psychological factors on pain outcomes: lessons learned for the next generation of research. Pain Rep. 2023;8(6):e1112. https:\/\/doi.org\/10.1097\/PR9.0000000000001112.","journal-title":"Pain Rep."},{"issue":"20","key":"3567_CR47","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433\u201345. https:\/\/doi.org\/10.1001\/archinte.163.20.2433.","journal-title":"Arch Intern Med"},{"issue":"1","key":"3567_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/gim.0b013e31802d830d","volume":"9","author":"SG Mehta","year":"2007","unstructured":"Mehta SG, Watts GD, Adamson JL, Hutton M, Umberger G, Xiong S, et al. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genet Med. 2007;9(1):9\u201313. https:\/\/doi.org\/10.1097\/gim.0b013e31802d830d.","journal-title":"Genet Med"},{"issue":"12","key":"3567_CR49","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1172\/JCI61126","volume":"121","author":"CC Weihl","year":"2011","unstructured":"Weihl CC. Another VCP interactor: NF is enough. J Clin Invest. 2011;121(12):4627\u201330. https:\/\/doi.org\/10.1172\/JCI61126.","journal-title":"J Clin Invest"},{"issue":"1","key":"3567_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2011.07.006","volume":"18","author":"N Chan","year":"2012","unstructured":"Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, et al. Valosin-containing protein mutation and Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(1):107\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.07.006.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03567-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03567-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03567-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T08:03:22Z","timestamp":1744704202000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03567-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3567"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03567-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.18.24311141","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individuals. This study was approved by the University of California Irvine Institutional Review Board (IRB) (#2007\u20135832).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all the subjects included in the study. In the case of deceased patients, they provided their consents prior to their demise.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}